Sotagliflozin is an oral dual sodium-glucose co-transporter types 1 and 2 (SGLT1/SGLT2) inhibitor. The FDA panel voted against the approval of sotagliflozin for patients with type 1 diabetes and ...
Colorectal cancer and liver cancer are the second and fifth most common cancers in Hong Kong, respectively, and both are associated with notably high mortality rates. This underscores the urgent need ...
November is National Diabetes Month, and the Food for Life plant-based nutrition and cooking class program is launching Wipe Out Diabetes to help people prevent, improve, and, in some cases, reverse ...